2022
DOI: 10.3389/frai.2022.932665
|View full text |Cite
|
Sign up to set email alerts
|

Rare disease-based scientific annotation knowledge graph

Abstract: Rare diseases (RDs) are naturally associated with a low prevalence rate, which raises a big challenge due to there being less data available for supporting preclinical and clinical studies. There has been a vast improvement in our understanding of RD, largely owing to advanced big data analytic approaches in genetics/genomics. Consequently, a large volume of RD-related publications has been accumulated in recent years, which offers opportunities to utilize these publications for accessing the full spectrum of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

3
2

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 17 publications
0
5
0
Order By: Relevance
“…The findings from Bisulli et al [ 72 ] proved the inference introduced for this particular case. In the future study, we will attach relevant references gathered from the previously developed scientific annotation knowledge graph, [ 73 ] to the merged nodes, as scientific evidence enrichment.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The findings from Bisulli et al [ 72 ] proved the inference introduced for this particular case. In the future study, we will attach relevant references gathered from the previously developed scientific annotation knowledge graph, [ 73 ] to the merged nodes, as scientific evidence enrichment.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, during the step of high-influence node identification, we manually searched for scientific evidence to support our findings. In the future study, we will programmatically query the rare disease-based scientific annotation knowledge graph [ 73 ] for evidence collection. In the future study, we will adopt/extend the strategy of network optimization to apply on the datasets with well-defined data models underneath, then we will be able to generate highly condensed graphs by merging nodes/relationships by different concept types.…”
Section: Discussionmentioning
confidence: 99%
“…In addition to supporting GARD, DRDRI staff members also participate in collaborative rare disease informatics research on topics including rare disease epidemiology [6] and artificial intelligence [7] .…”
Section: The Genetic and Rare Diseases Information Centermentioning
confidence: 99%
“…The ndings from Bisulli et al [72] proved the inference introduced for this particular case. In the future study, we will attach relevant references gathered from the previously developed scienti c annotation knowledge graph, [73] to the merged nodes, as scienti c evidence enrichment.…”
Section: A Observations and Findingsmentioning
confidence: 99%
“…Additionally, during the step of high-in uence node identi cation, we manually searched for scienti c evidence to support our ndings. In the future study, we will programmatically query the rare disease-based scienti c annotation knowledge graph [73] for evidence collection. In the future study, we will adopt/extend the strategy of network optimization to apply on the datasets with well-de ned data models underneath, then we will be able to generate highly condensed graphs by merging nodes/relationships by different concept types.…”
Section: B Limitations Of This Studymentioning
confidence: 99%